Erlotinib in Combination With Pralatrexate in Advanced Malignancies

Clinical trial NCT01532011 · COMPLETED

Trial details

NCT number: NCT01532011
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancers Solid Tumors

Start date: 2012-03-01
Primary completion: 2016-06-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.